-39.3%
PDD vs GSK
+11.3%
-50.5%
-46.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | -0.2% | -0.9% | -1.1% |
| 7D | +5.6% | +1.7% | +4.0% | +5.3% |
| 30D | +5.8% | +7.0% | -1.3% | +4.5% |
| 3M | -8.6% | -2.7% | -6.0% | -8.3% |
| 6M | -18.8% | +1.4% | -20.3% | -19.5% |
| YTD | -26.8% | +5.3% | -32.1% | -28.8% |
| 1Y | -39.3% | +10.6% | -49.9% | -41.9% |
| All | -39.3% | +11.3% | -50.5% | -41.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling